MDxHealth director reports 10,000 share options

MDxHealth SA director Sanford Jay Siegel filed an initial ownership report showing compensation-related options, not a market trade.

Rhea-AI Filing Summary

MDxHealth SA director Sanford Jay Siegel filed an initial ownership report showing compensation-related options, not a market trade. He holds options to purchase 10,000 ordinary shares at $2.18 per share, granted on June 27, 2025, vesting in full at the next-year annual general shareholders' meeting and expiring on June 27, 2035.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Siegel Sanford Jay

Role Director

Type	Security	Shares	Price	Value
holding	Share Option	--	--	--

Holdings After Transaction: Share Option — 10,000 contracts (Direct)

Footnotes (1)

1. F1. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $2.18 granted on June 27, 2025 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

Key Figures

Option grant size: 10,000 shares Exercise price: $2.18 per share Option expiration: June 27, 2035 +1 more

4 metrics

Option grant size 10,000 shares Underlying ordinary shares for director options

Exercise price $2.18 per share Strike price of director share options

Option expiration June 27, 2035 Expiration date of share options

Shares underlying options after filing 10,000 shares Total underlying ordinary shares following report

Key Terms

Share Option, Ordinary Shares, annual general shareholders' meeting

3 terms

Share Option financial

"security_title: "Share Option""

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

annual general shareholders' meeting financial

"vest in full on the date of the annual general shareholders' meeting"

A yearly meeting where a company’s shareholders and board of directors come together to review performance, vote on key issues (such as electing directors and approving auditors), and ask questions of management. Think of it like a town-hall or annual check-in where owners can influence how the company is run; outcomes can affect governance, dividend decisions and long-term strategy, all of which can influence the value and risks of an investor’s holdings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MDxHealth (MDXH) director Sanford Siegel report on this Form 3?

Sanford Siegel reports holding options to buy 10,000 MDxHealth ordinary shares at $2.18 per share. These options are a compensation award, not an open-market trade, and represent his initial disclosed derivative position as a company director.

Is Sanford Siegel buying or selling MDxHealth (MDXH) shares in this filing?

No, this Form 3 does not show any MDxHealth share purchases or sales. It only reports existing options to acquire 10,000 ordinary shares at $2.18, granted as compensation and disclosable as his initial beneficial ownership position.

What are the key terms of Sanford Siegel’s MDxHealth (MDXH) share options?

The options cover 10,000 ordinary shares at an exercise price of $2.18 per share. They were granted on June 27, 2025, and vest in full at the annual general shareholders’ meeting in the following calendar year, with an expiration date of June 27, 2035.

When do Sanford Siegel’s MDxHealth (MDXH) options vest and expire?

The options vest in full on the date of the annual general shareholders’ meeting held in the calendar year after grant. They were granted June 27, 2025 and expire June 27, 2035, giving a long-term incentive horizon through that expiration date.

How many MDxHealth (MDXH) shares could Sanford Siegel acquire from these options?

If fully exercised, the options allow acquisition of 10,000 MDxHealth ordinary shares at $2.18 per share. This represents his disclosed derivative entitlement under this award and defines the maximum underlying share count tied to this specific option grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/09/2026 - 04:09 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Siegel Sanford Jay

(Last) (First) (Middle)

CAP BUSINESS CENTER

ZONE INDUSTRIELLE DES HAUTS-SARTS

(Street)

HERSTAL BELGIUM 4040

(City) (State) (Zip)

BELGIUM

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
MDxHealth SA [ MDXH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option	(1)	06/27/2035	Ordinary Shares	10,000	$2.18	D

Explanation of Responses:

1. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $2.18 granted on June 27, 2025 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

	/s/ Mark Busch, as attorney-in-fact for Sanford Jay Siegel	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)